Efficacy of a Hydrogel Pad Cooling Device for induction, maintenance, and rewarming during mild hypothermia treatment in the post cardiac arrest and neuro.

Slides:



Advertisements
Similar presentations
Numbers Treasure Hunt Following each question, click on the answer. If correct, the next page will load with a graphic first – these can be used to check.
Advertisements

1
© 2008 Pearson Addison Wesley. All rights reserved Chapter Seven Costs.
Copyright © 2003 Pearson Education, Inc. Slide 1 Computer Systems Organization & Architecture Chapters 8-12 John D. Carpinelli.
Copyright © 2011, Elsevier Inc. All rights reserved. Chapter 6 Author: Julia Richards and R. Scott Hawley.
STATISTICS HYPOTHESES TEST (I)
Design of Dose Response Clinical Trials
The Application of Propensity Score Analysis to Non-randomized Medical Device Clinical Studies: A Regulatory Perspective Lilly Yue, Ph.D.* CDRH, FDA,
OPTN Modifications to Heart Allocation Policy Implemented July 12, 2006 Changed the allocation order for medically urgent (Status 1A and 1B) patients Policy.
UNITED NATIONS Shipment Details Report – January 2006.
David Burdett May 11, 2004 Package Binding for WS CDL.
NTDB ® Annual Report 2009 © American College of Surgeons All Rights Reserved Worldwide Facilities by Pediatric Hospital Association Figure 1.
NTDB ® Annual Pediatric Report 2010 © American College of Surgeons All Rights Reserved Worldwide National Trauma Data Bank 2010 Pediatric Report.
NTDB ® Annual Report 2009 © American College of Surgeons All Rights Reserved Worldwide Percent of Hospitals Submitting Data to NTDB by State and.
NTDB ® Annual Report 2010 © American College of Surgeons All Rights Reserved Worldwide National Trauma Data Bank 2010 Annual Report.
HAIST HAIST The Hypothermia for Acute Ischaemic Stroke Trial Malcolm Macleod PhD FRCPE Senior Lecturer, Clinical Neurosciences, University of Edinburgh.
1 RA I Sub-Regional Training Seminar on CLIMAT&CLIMAT TEMP Reporting Casablanca, Morocco, 20 – 22 December 2005 Status of observing programmes in RA I.
Exit a Customer Chapter 8. Exit a Customer 8-2 Objectives Perform exit summary process consisting of the following steps: Review service records Close.
Create an Application Title 1Y - Youth Chapter 5.
CALENDAR.
Lecture 2 ANALYSIS OF VARIANCE: AN INTRODUCTION
Supported by ESRC Large Grant. What difference does a decade make? Satisfaction with the NHS in Northern Ireland in 1996 and 2006.
Chapter 7 Sampling and Sampling Distributions
The 5S numbers game..
1. 2 Objectives Become familiar with the purpose and features of Epsilen Learn to navigate the Epsilen environment Develop a professional ePortfolio on.
REVIEW: Arthropod ID. 1. Name the subphylum. 2. Name the subphylum. 3. Name the order.
Break Time Remaining 10:00.
PP Test Review Sections 6-1 to 6-6
Chi-Square and Analysis of Variance (ANOVA)
2014 National Patient Safety Goals
Copyright © 2012, Elsevier Inc. All rights Reserved. 1 Chapter 7 Modeling Structure with Blocks.
1 RA III - Regional Training Seminar on CLIMAT&CLIMAT TEMP Reporting Buenos Aires, Argentina, 25 – 27 October 2006 Status of observing programmes in RA.
Basel-ICU-Journal Challenge18/20/ Basel-ICU-Journal Challenge8/20/2014.
1..
THE CLINICAL EFFICACY OF REPEAT BRAIN CT IN PATIENTS WITH TRAUMATIC INTRACRANIAL HAEMORRHAGE WITHIN 24 HRS AFTER BLUNT HEAD INJURY.
Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experience of Research Findings and Opportunities From NCPES (National.
MaK_Full ahead loaded 1 Alarm Page Directory (F11)
1 Termination and shape-shifting heaps Byron Cook Microsoft Research, Cambridge Joint work with Josh Berdine, Dino Distefano, and.
Subtraction: Adding UP
: 3 00.
5 minutes.
© The McGraw-Hill Companies, Inc., Chapter 10 Testing the Difference between Means and Variances.
Essential Cell Biology
Converting a Fraction to %
Chapter Thirteen The One-Way Analysis of Variance.
Clock will move after 1 minute
PSSA Preparation.
Module 20: Correlation This module focuses on the calculating, interpreting and testing hypotheses about the Pearson Product Moment Correlation.
Immunobiology: The Immune System in Health & Disease Sixth Edition
Energy Generation in Mitochondria and Chlorplasts
Select a time to count down from the clock above
Murach’s OS/390 and z/OS JCLChapter 16, Slide 1 © 2002, Mike Murach & Associates, Inc.
Copyright Tim Morris/St Stephen's School
A Member of Mennen Medical Group MTRE Advanced Technologies Medical Thermo Regulation Expertise A Member of Mennen Medical Group July 2010.
Chapter 5 The Mathematics of Diversification
Addison K. May, MD, FACS, FCCM Professor of Surgery and Anesthesiology
The role of continuous EEG in therapeutic hypothermia
Therapeutic Hypothermia in Out of Hospital Cardiac Arrest towards
The S.P.A.R.C Network Insert sparc logo here. The Facts… arrests/ 100,000 people arrests/ 100,000 people 60% of CA patients die in-hospital.
Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.
Complications & Re-warming
Introduction Therapeutic hypothermia has been shown to improve survival and neurologic outcome in patients resuscitated after ventricular fibrillation.
Induced Hypothermia After VF Cardiac Arrest Improves Outcomes Summary and Comment by Kristi L. Koenig, MD, FACEP Published in Journal Watch Emergency Medicine.
University of Rhode Island BME 482 Kasey Tipping.
Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function R3 김동연 /Prof. 정경환 N Engl J Med 373;5 July 30, 2015.
Post-Cardiac Arrest Therapeutic Hypothermia Laura Bagley, Cali Roen, Anthony Schuler, Amy Weaver BME 301 March 7, 2008.
POST-CARDIAC ARREST THERAPEUTIC HYPOTHERMIA Laura Bagley, Calista Roen, Anthony Schuler, Amy Weaver Client: Dr. Darren Bean Advisor: Willis Tompkins References.
Therapeutic Hypothermia
Endovascular Selective Cerebral Hypothermia for Neuroprotection
Presentation transcript:

Efficacy of a Hydrogel Pad Cooling Device for induction, maintenance, and rewarming during mild hypothermia treatment in the post cardiac arrest and neuro patient populations Mission Hospital – Mission Viejo CA 1 UCLA Los Angeles CA 2 Mary Kay Bader RN 1, Teresa Wavra RN 1, Robert McCary RN 2, Joy Toyama MS 2, George Schiffman MD 1, and Jon Cline MD 1 Conclusion: Patients undergoing mild hypothermia were rapidly cooled to the goal temp of °C within hours using a hydrogel pad surface cooling device. Overshooting the target temperature occurred in 3 of the 40 patients. Rewarming to 37°C was well controlled in both populations. There were several patient records that had incomplete clinical data therefore they were not included in the statistical analysis. Overall, the organizations cooling method and protocol were able to deliver a well controlled hypothermia treatment while minimizing overshooting of the target temperature. Results: 28 post cardiac arrest patients and 28 neuro patients had orders to induce mild hypothermia starting in September patients were excluded due to: a) target temperature ordered to 35°C [6 neuro], b) no available medical record [3], c) hemodynamic instability leading to aborted procedures [3 cardiac], d) poor documentation [3] with inability to obtain accurate data, and e)1st documented temperature of 33°C with incomplete documentation [3]). Data from 40 patients were included for analysis. In the neuro patients, mean values were 43.1 (age), (BSA) and (BMI). In the cardiac patients, mean values were 58.7 (age), (BSA), and (BMI). Induction cooling time to target of 33°C was hours with a mean cooling rate of 1.43°C/hr for the neuro patients and 2.8 hours with a mean cooling rate of 1.2°C/hr for the cardiac patients. Using the Pearson Correlation, a significant association between the degree/hr decrease for both BMI and BSA was determined: BMI p- value= ; BSA p-value= at a significant level of p=0.05. Overshooting the lower temperature threshold of 32°C occurred in 0 of 20 neuro patients and 3 of 20 cardiac patients with the lowest temperature recorded at 31.5°C. Rewarming rates were well controlled for both populations (0.25°C/hour in cardiac patients/spinal injury and 0.05°C/hour in brain injury patients). Introduction: The implementation of mild hypothermia (32-34°C) in post cardiac arrest (HACA) ameliorates the hypoxic/anoxic damage in the brain. Mild hypothermia has been deployed in neuro patients with refractory increased intracranial pressure, severe vasospasm, stroke, and injury to the brain/spine. The challenge in implementing this therapy is using a cooling system that rapidly induces the target temperature of 32-34°C without overshooting the temperature, maintaining the target temperature, and rewarming slowly to reduce rebound cerebral swelling and minimize the electrolyte shifts that occur as patients return to 37°C. This study examined two patient populations at one community hospital where mild hypothermia was used to reduce neurologic injury post cardiac arrest and in critical neuro patients using a hydrogel pad surface cooling system. Methods: A retrospective review of all patients treated with mild hypothermia post- cardiac arrest or for severe neurologic injury over the last three years was conducted. An analysis of the medical records was done. Data abstracted included age, body surface area (BSA), and body mass index (BMI) as well as bladder temperatures obtained every 15 to 60 minutes during the hypothermia period. Induction time (defined as the active rate of cooling from start to target temperature), overshooting target temperature (defined as temperatures below 32°C) and control of rewarming at the prescribed rate were assessed. HACA Patient Population Individual Temperature Curves Variable Analysis Neuro Population HACA Population Statistical Analysis Neuro PopulationHACA Population Neuro Patient Population Individual Temperature Curves Poster 353